HEALTHCARE WORKERS COHORT
SCOPE STUDY (SURVEYS)
LONG COVID among Healthcare Workers (HCWs: burden and KAP study (surveys)
The study is an iniciative of the WHO HCW project, lead by Iris Finci– Consultant Epidemiologist from WHO Regional Office for Europe- and EuCARE has been asked to have participating centers
The information is updated on a regular basis*
WHY FOCUS ON HCWs
- HCWs are at high risk for SARS-CoV-2 infection during the pandemic
- 40% prevalence of Long Covid (LC) among infected HCWs (meta-analysis, 2025)
- Limited data on HCWs’ knowledge, attitudes, and practices (KAP) towards LC
- HCWs’ perceptions influence patient diagnosis and care
Study Design
Cross-sectional survey using two independent electronic questionnaires
Study population and Inclusion: ≥18 years, active HCW in participating countries
Surveys hosted on Google Form or REDCap or similar secure platforms
Data anonymized and stored securely per GDPR
OBJECTIVE(S) OF THE SURVEY
Objective 1 (survey 1)- Burden
Sample size:
Survey 1 (burden) – expected 308 participants per site
- To estimate prevalence and impact of LC among HCWs since 2020, including its prevalence and impact on quality of life since the start of the COVID-19 pandemic in 2020
- All kind of HCWs are invited to participate (clinical and non-clinical)
- Survey: COVID history, LC symptoms, quality of life impact
Objective 2 (survey 2)- KAP
Sample size:
Survey 2 (KAP) – eexpected 480 participants per site
- To explore HCWs’ knowledge, attitudes, and practices related to LC
- Exclusive for HCWs who have direct contact with patients and may diagnose or manage LC patients (ex: MDs, GPs, nurses)
- Survey 2: LC knowledge, attitudes, practices, diagnosis, and management
EXPECTED IMPACT AND NEXT STEPS
Fill knowledge gaps on LC burden and HCWs’ KAP in Europe region and Hong Kong
Inform resource allocation, training, and policy development
Share findings via reports, scientific publications, and presentations
PARTICIPANTS
| EUCARE | Principal Investigator |
| ASST (Milan, Italy) | Giulia Marchetti |
| ULSLO (Libon, Portugal) | Cristina Toscano |
| FUMG (Minas Gerais, Brazil) | Júlia Caporali |
| HHU (Dusseldörf, Germany) | Björn Jensen |
| PUM (Szczecin, Poland) | Milösz Parczewski |
| Tor Vergata (Rome, Italy) | Francesca Ceccherini Silberstein |
| VULSK (Lithuany, Lithuany) | Dovilé Juozapaite |
| Other countries participating (WHO region) |
| Albania |
| Armenia |
| Azerbeijan |
| Georgia |
| Hong Kong Special Administrative Region |
| Ireland |
| Israel |
| Portugal (National Health Institute) |
| United Kingdom (part 1 only) |